Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Mark J, Benvenga"'
Autor:
Mark J. Benvenga, Stephen F. Chaney, Melvyn Baez, Thomas C. Britton, William J. Hornback, James A. Monn, Gerard J. Marek
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
There is substantial evidence that glutamate can modulate the effects of 5-hydroxytryptamine2A (5-HT2A) receptor activation through stimulation of metabotropic glutamate2/3 (mGlu2/3) receptors in the prefrontal cortex. Here we show that constitutive
Externí odkaz:
https://doaj.org/article/9f965940a60d4dd5ac6205b068ebae96
Autor:
Thomas Edward Fitch, Mark J Benvenga, Cynthia D Jesudason, Charity eZink, Amy B Vandergriff, Michelle eMenezes, Douglas A Schober, Linda M Rorick-Kehn
Publikováno v:
Frontiers in Neuroscience, Vol 8 (2014)
We describe a novel, potent and selective orexin-2 (OX2)/hypocretin-2 receptor antagonist with in vivo activity in an animal model predictive of antidepressant-like efficacy. N-biphenyl-2-yl-4-fluoro-N-(1H-imidazol-2-ylmethyl)benzenesulfonamide HCl (
Externí odkaz:
https://doaj.org/article/c842bba9e61d4eb8b6fd10b90297f0f5
Autor:
Mark J, Benvenga, Stephen F, Chaney, Melvyn, Baez, Thomas C, Britton, William J, Hornback, James A, Monn, Gerard J, Marek
Publikováno v:
Frontiers in Pharmacology
There is substantial evidence that glutamate can modulate the effects of 5-hydroxytryptamine2A (5-HT2A) receptor activation through stimulation of metabotropic glutamate2/3 (mGlu2/3) receptors in the prefrontal cortex. Here we show that constitutive
Autor:
Mark J. Benvenga, Michael A. Statnick, Karen M. Knitowski, Julie Foss, Miguel A. Toledo, Alfonso Benito, Anke Post, Kirsti Lloyd, Michael Ansonoff, Alma Jiménez, Vanessa N. Barth, Maria Angeles Martinez-Grau, Janice W. Smith, Scott D. Gleason, Celia Lafuente, Linda M. Rorick-Kehn, John T. Catlow, Conception Pedregal, Nuria Diaz, Julie F. Falcone, Kjell A. Svensson, John E. Pintar, Steven Chaney, Xia Li, David L. McKinzie, Benjamin L. Adams, Jeffrey M. Witkin
Publikováno v:
Pharmacology Research & Perspectives
Nociceptin/Orphanin FQ (N/OFQ) is a 17 amino acid peptide whose receptor is designated ORL1 or nociceptin receptor (NOP). We utilized a potent, selective, and orally bioavailable antagonist with documented engagement with NOP receptors in vivo to ass
Autor:
Patrick L. Love, Paul A. Ardayfio, John T. Catlow, Mark J. Benvenga, Stephen F. Chaney, Steven P. Swanson, Gerard J. Marek
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 327:891-897
Previous work has suggested that N-methyl-d-aspartate (NMDA) receptor antagonism and 5-hydroxytryptamine (5-HT)(2A) receptor blockade may enhance and attenuate, respectively, certain types of impulsivity mediated by corticothalamostriatal circuits. M
Autor:
Miles Goodman Siegel, Peggy L. Surface, Nuria Diaz, Jamie H. McKinzie, Ryan Favors, Mark J. Benvenga, Joseph M. Woodland, Michael A. Statnick, Nita J. Patel, Elizabeth Marie Thomas, Paul J. Emmerson, Steven C. Peters, Michael Mangold, Charles H. Mitch, Harlan E. Shannon, Steven James Quimby
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 15:3844-3848
The phenolic hydroxy group of opiate-derived ligands is of known importance for biological activity. We have developed a SAR study around LY255582 by comparing the effect of the hydroxy group in the 2- and 4-position of the phenyl ring. Also, we have
Autor:
Charity Zink, Cynthia Darshini Jesudason, Thomas E. Fitch, Mark J. Benvenga, Michelle M Menezes, Amy B Vandergriff, Linda M. Rorick-Kehn, Douglas A. Schober
Publikováno v:
Frontiers in Neuroscience
Frontiers in Neuroscience, Vol 8 (2014)
Frontiers in Neuroscience, Vol 8 (2014)
We describe a novel, potent and selective orexin-2 (OX2)/hypocretin-2 receptor antagonist with in vivo activity in an animal model predictive of antidepressant-like efficacy. N-biphenyl-2-yl-4-fluoro-N-(1H-imidazol-2-ylmethyl)benzenesulfonamide HCl (
Publikováno v:
Drug Development Research. 47:37-44
Compounds which affect glutamate transmission are reported as anxiolytic in a number of animal models. In the present studies, we evaluated the anxiolytic effect of a new mGluR2 agonist, LY354740, in rats and pigeons. LY354740 was evaluated in three
Autor:
David O. Calligaro, David L. Nelson, Susan K. Hemrick-Luecke, Mary C. Wolff, James B. Lucot, Jaswant Singh Gidda, Mark J. Benvenga, Carl D Overshiner, Ray W. Fuller, J. David Leander
Publikováno v:
Drug Development Research. 40:17-34
LY301317 ((4r)-(-)-4-(dipropylamino)-6-(5-oxazolinyl)-1,3,4,5-tetrahydrobenz[c,d]indole) has high affinity for the 5-HT 1A receptor and weak affinity for the 5-HT 1D and histamine-H 1 receptors. No significant affinity was found for the other amine r